End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.39 CNY | +1.06% | +9.41% | +3.92% |
Apr. 19 | Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 10 | Fangsheng Pharma's Factories Pass GMP Inspection | MT |
Sales 2023 | 1.63B 225M | Sales 2024 * | 2.1B 290M | Capitalization | 5.01B 691M |
---|---|---|---|---|---|
Net income 2023 | 187M 25.81M | Net income 2024 * | 225M 31.06M | EV / Sales 2023 | 2.96 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 2.38 x |
P/E ratio 2023 |
26.1
x | P/E ratio 2024 * |
22.3
x | Employees | 1,600 |
Yield 2023 |
1.82% | Yield 2024 * |
0.88% | Free-Float | 59.54% |
1 day | +1.06% | ||
1 week | +9.41% | ||
Current month | +1.24% | ||
1 month | +2.89% | ||
3 months | +15.87% | ||
6 months | +15.28% | ||
Current year | +3.92% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Li Zhou
CEO | Chief Executive Officer | 51 | - |
Zai Chang Liu
DFI | Director of Finance/CFO | 50 | 21-06-16 |
43 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xue Min Gao
BRD | Director/Board Member | 86 | 23-09-18 |
Shou Ying Du
BRD | Director/Board Member | 64 | 20-04-30 |
Xiong Yuan
BRD | Director/Board Member | 59 | 21-11-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 11.39 | +1.06% | 6,568,831 |
24-04-22 | 11.27 | +3.30% | 13,255,060 |
24-04-19 | 10.91 | +4.40% | 5,946,013 |
24-04-18 | 10.45 | -1.23% | 3,242,431 |
24-04-17 | 10.58 | +4.44% | 5,221,331 |
End-of-day quote Shanghai S.E., April 22, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.92% | 684M | |
+17.88% | 44.31B | |
+19.87% | 22.17B | |
+13.05% | 14.62B | |
+8.06% | 13.12B | |
+39.21% | 11.58B | |
-8.96% | 6.96B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+5.03% | 5.03B |
- Stock Market
- Equities
- 603998 Stock